Specifically, the increased expression of Claudin-1 in colon cancer correlated with metastasis and poor prognosis40–42, and with poor outcome in high grade invasive ductal carcinoma of the breast where it correlated with the molecular subtype43. The gene discussed is CLDN1; the disease is malignant colon neoplasm.